Cubist Pharmaceuticals
The Shape Of Cures To Come.™
About Cubist
Products
&
Pipeline
Investor Relations
Careers
News
&
Media
Search
News
&
Media
18
Apr
Cubist Reports First Quarter 2013 Financial Results
Thursday Apr. 18th 2013
11
Mar
Cubist Obtains Remaining Rights to Ceftolozane from Astellas
Agreement Results in Cubist Owning Worldwide Rights to Ceftolozane/Tazobactam
Monday Mar. 11th 2013
28
Feb
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
Thursday Feb. 28th 2013
View All News
Upcoming Events
3
Jun
Jefferies 2013 Global Healthcare Conference
Monday Jun. 3rd 2013
12
Jun
Cubist Pharmaceuticals Annual Meeting of Shareholders
Wednesday Jun. 12th 2013
View All Upcoming Events
Search Cubist.com
Loading